Unique ID issued by UMIN | UMIN000038328 |
---|---|
Receipt number | R000043545 |
Scientific Title | Retrospective study of liver reserve capacity evaluation using GSA SPECT and MRI in patients with liver tumor who treated by carbon ion radiotherapy |
Date of disclosure of the study information | 2019/10/30 |
Last modified on | 2021/10/20 15:22:09 |
Retrospective study of liver reserve capacity evaluation using GSA SPECT and MRI in patients with liver tumor who treated by carbon ion radiotherapy
Retrospective study of liver reserve capacity evaluation using GSA SPECT and MRI in patients with liver tumor who treated by carbon ion radiotherapy
Retrospective study of liver reserve capacity evaluation using GSA SPECT and MRI in patients with liver tumor who treated by carbon ion radiotherapy
Retrospective study of liver reserve capacity evaluation using GSA SPECT and MRI in patients with liver tumor who treated by carbon ion radiotherapy
Japan |
Liver tumor
Radiology |
Malignancy
NO
To assess the method using GSA SPECT and MRI before and after carbon ion radiotherapy in patients with liver tumor
1. Liver reserve capacity evaluation
2. Early treatment response and prognosis
Efficacy
Assessment of diagnostic abilities of GSA SPECT or MRI in terms of prediction of residual liver reserve capacity before and 3, 12 months after carbon ion radiotherapy
Correlation among overall survival rate, treatment completion rate in intent to treat group, liver function indices such as Child-Pugh classification, and other clinical data
Observational
Not applicable |
Not applicable |
Male and Female
Patients underwent GSA SPECT and MRI, among who were / will be treated with carbon ion radiotherapy for liver tumors from December 2018 to September 2020 at QST hospital.
1.Other cause of death within 12 months after carbon ion radiotherapy.
2.Recurrence cases within 12 months after carbon ion therapy.
3.Patients who were received other anticancer treatments within 4 months after carbon ion radiotherapy.
4.Patients who refuse to participate in this study.
50
1st name | Ryuichi |
Middle name | |
Last name | Nishii |
National Institute of Radiological Sciences (NIRS), QST
Dept. of Molecular Imaging and Theranostics
263-8555
4-9-1 Anagawa, Inage-ku, Chiba
043-206-4074
nishii.ryuichi@qst.go.jp
1st name | Kana |
Middle name | |
Last name | Yamazaki |
National Institute of Radiological Sciences (NIRS), QST
Dept. of Molecular Imaging and Theranostics
263-8555
4-9-1 Anagawa, Inage-ku, Chiba
043-206-4076
yamazaki.kana@qst.go.jp
National Institute of Radiological Sciences (NIRS), QST
None
Self funding
Certified Review Board, QST
4-9-1 Anagawa, Inage-ku
043-206-4706
helsinki@qst.go.jp
NO
2019 | Year | 10 | Month | 30 | Day |
Unpublished
110
Completed
2019 | Year | 10 | Month | 16 | Day |
2019 | Year | 10 | Month | 16 | Day |
2019 | Year | 10 | Month | 18 | Day |
2021 | Year | 09 | Month | 30 | Day |
Observational study
2019 | Year | 10 | Month | 18 | Day |
2021 | Year | 10 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043545
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |